Publication: Efficacy of quantitative capillary beta-hydroxybutyrate measurement in the diagnosis of diabetic ketoacidosis: A comparison to quantitative serum ketone measurement by nitroprusside reaction
Issued Date
2014-01-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-84900005518
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.97, No.3 SUPPL. 3 (2014)
Suggested Citation
Raweewan Lertwattanarak, Parit Plainkum Efficacy of quantitative capillary beta-hydroxybutyrate measurement in the diagnosis of diabetic ketoacidosis: A comparison to quantitative serum ketone measurement by nitroprusside reaction. Journal of the Medical Association of Thailand. Vol.97, No.3 SUPPL. 3 (2014). Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/34418
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Efficacy of quantitative capillary beta-hydroxybutyrate measurement in the diagnosis of diabetic ketoacidosis: A comparison to quantitative serum ketone measurement by nitroprusside reaction
Author(s)
Other Contributor(s)
Abstract
Objective: To examine the efficacy of using capillary beta-hydroxy butyrate (β-OHB) levels in comparison with serum ketone levels in distinguishing diabetic ketoacidosis (DKA) from non-DKA states in patients who had severe hyperglycemia and to determine a cut-off level of capillary β-OHB that is best for the diagnosis of DKA. Material and Method: Diabetic patients who presented with capillary blood glucose of >400 mg/dL were studied. Capillary β-OHB levels were measured by using a ketometer (OptiumXceed™) at the same time as blood sample collection for biochemical tests and serum ketone measurement using nitroprusside reaction. The American Diabetes Association (ADA) criteria 2012 were used as the gold standard in the diagnosed of DKA. Results: There were 13 cases (34.2%) with DKA (DKA group) and 25 cases (65.8%) without DKA (non-DKA group). There was no difference in plasma glucose levels between both groups. (DKA group = 714.2±367.6 mg/dl vs. non-DKA group = 589.4±220.2 mg/dl). The DKA group had significantly higher serum ketone (7.2±3.6 vs. 0.28±0.05 mmol/L, p<0.001) and capillary β-OHB levels (4.3±0.7 vs. 1.0±1.1 mmol/L, p<0.001) than did the non-DKA group. Capillary β-OHB levels significantly correlated to serum anion gap values (r = 0.828, p<0.001), serum bicarbonate (r = 0.715, p<0.001), and ketone (r = 0.72, p<0.001) levels. ROC analyses showed that a capillary β-OHB level of >3.1 mmol/L was the best cut-off level for the diagnosis of DKA, and yielded a sensitivity of 100% (95% CI = 75.1-100) with a specificity of 96% (95% CI = 79.6-99.3). Conclusion: Using a cut-off capillary β-OHB level of >3.1 mmol/L is highly effective in the diagnosis of DKA in patients who presented with hyperglycemia. Quantitative measurement of capillary β-OHB levels using a ketometer offers an immediate result that is useful for a reliable triage of screening for DKA in patients presented with severe hyperglycemia.